# Global Research Context

This research investigates the complex pathophysiological pathway linking endometriosis to chronic fatigue syndrome through a cascade of interconnected mechanisms. The central thesis proposes that endometriosis, characterized by ectopic endometrial tissue and chronic inflammatory processes, can disrupt gastrointestinal function and promote small intestinal bacterial overgrowth (SIBO). This potential SIBO-endometriosis combination can create a state of amplified systemic inflammation through bacterial endotoxin release and immune dysregulation, which may subsequently disrupt thyroidal and neuroendocrine function via suppression of the hypothalamic-pituitary-thyroid axis and impairment of peripheral thyroid hormone metabolism. The resulting metabolic suppression, neuroinflammation, and perpetuation of pathological inflammatory cycles can ultimately manifest as chronic fatigue syndrome, creating a self-reinforcing pathological state that requires integrated therapeutic approaches targeting multiple pathways simultaneously.

# Focus Statement

**Affirmation under study:** SIBO in endometriosis patients leads to increased LPS and flagellin release from gram-negative bacteria

# Pathophysiological Analysis

Endometriosis creates a pathophysiological environment that predisposes patients to small intestinal bacterial overgrowth (SIBO) through multiple interconnected mechanisms. The chronic inflammatory state characteristic of endometriosis, mediated by elevated pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, can directly impair gastrointestinal motility by disrupting the migrating motor complex (MMC) and reducing gastric acid production. Additionally, the physical presence of endometrial lesions within the pelvic cavity can create anatomical distortions and adhesions that mechanically compromise bowel function, while the associated chronic pain may lead to altered autonomic nervous system regulation of digestive processes.

When SIBO develops in this compromised gastrointestinal environment, the aberrant proliferation of gram-negative bacteria in the small intestine results in significantly increased production and release of bacterial endotoxins, particularly lipopolysaccharide (LPS) and flagellin. LPS, a major component of the outer membrane of gram-negative bacteria, acts as a potent pathogen-associated molecular pattern (PAMP) that activates toll-like receptor 4 (TLR4) on intestinal epithelial cells and immune cells. Simultaneously, flagellin, the structural protein of bacterial flagella, triggers TLR5 activation. Both pathways converge on NF-κB signaling cascades, amplifying local and systemic inflammatory responses through increased production of pro-inflammatory mediators including IL-1β, IL-6, TNF-α, and interferon-γ.

This LPS and flagellin-mediated inflammatory amplification creates a critical pathophysiological bridge between localized endometriosis and systemic metabolic dysfunction. The sustained elevation of these bacterial endotoxins promotes intestinal permeability through tight junction disruption (particularly involving claudin and occludin proteins), facilitating bacterial translocation and endotoxemia. This systemic endotoxin burden subsequently activates hepatic Kupffer cells and triggers the acute-phase response, elevating circulating inflammatory markers such as C-reactive protein and pro-inflammatory cytokines. These inflammatory mediators can then cross-talk with neuroendocrine pathways, suppressing hypothalamic TRH release, blunting pituitary TSH responsiveness, and inhibiting peripheral thyroid hormone conversion through downregulation of type 1 deiodinase (DIO1) activity, ultimately contributing to the metabolic suppression and neuroinflammatory state characteristic of chronic fatigue syndrome.

# Literature Review

## Reference 1

**URL:** https://mdpi-res.com/d_attachment/microorganisms/microorganisms-10-00960/article_deploy/microorganisms-10-00960-v2.pdf

**Assessment:**

This prospective study by Rizos et al. provides strong mechanistic support for the affirmation by demonstrating that SIBO creates an indigenous proinflammatory environment in the duodenum through elevated cytokine production. The study employed rigorous methodology using gold-standard duodenal aspiration and culture techniques in 224 patients, directly measuring IL-1β, IL-6, and TNF-α levels in duodenal fluid rather than relying on serum markers. Key findings directly relevant to the pathophysiological pathway include a significant association between SIBO and elevated IL-1β levels (OR 2.61, p=0.037), with patients having all three elevated cytokines showing an even stronger association with SIBO (OR 3.47, p=0.03). Critically, the study used PCR analysis to identify that Klebsiella pneumoniae, a gram-negative bacterium, was positively associated with elevated IL-6 and TNF-α levels in duodenal fluid. While the study does not directly measure LPS or flagellin concentrations, it provides compelling evidence for the downstream inflammatory consequences that would result from increased endotoxin release from gram-negative bacteria in SIBO, specifically demonstrating the NF-κB-mediated cytokine amplification described in the pathophysiological analysis. The study's limitation is its focus on general SIBO patients rather than specifically endometriosis patients, though the inflammatory mechanisms identified would be expected to operate similarly in the endometriosis-SIBO context.

## Reference 2

**URL:** https://journals.sagepub.com/doi/10.5301/je.5000229

**Assessment:**

This review by Takebayashi et al. provides compelling support for the affirmation by demonstrating the direct involvement of gram-negative bacteria and their LPS endotoxins in endometriosis pathophysiology through the bacterial contamination hypothesis. The study found higher intrauterine microbial colonization in women with endometriosis compared to controls, establishing a mechanistic foundation for increased LPS exposure in these patients. Crucially, the research examined the stimulatory effects of E. coli-derived LPS on macrophage secretion of inflammatory macromolecules involved in endometriosis, demonstrating the TLR4-mediated proinflammatory cascade that aligns precisely with the NF-κB signaling pathway described in the pathophysiological analysis. The study also revealed LPS's growth-promoting effects on endometrial cells, suggesting that bacterial endotoxins not only trigger systemic inflammation but may also directly contribute to ectopic tissue proliferation. While this research focuses on intrauterine bacterial contamination rather than SIBO-derived LPS, it establishes the critical mechanistic link between gram-negative bacterial endotoxins and endometriosis pathophysiology, supporting the concept that increased LPS exposure (whether from intrauterine sources or SIBO) can amplify the inflammatory burden in endometriosis patients through TLR4-mediated pathways.

## Reference 3

**URL:** https://bmcmicrobiol.biomedcentral.com/articles/10.1186/1471-2180-4-33

**Assessment:**

This seminal study by Tallant et al. provides fundamental mechanistic support for the affirmation by demonstrating that flagellin is the primary bacterial factor responsible for activating NF-κB-mediated inflammatory pathways in intestinal epithelial cells, establishing the molecular foundation for how SIBO-associated gram-negative bacteria drive systemic inflammation. The study employed rigorous biochemical purification techniques, including gel permeation and anion exchange chromatography combined with mass spectrometry, to unambiguously identify flagellin as the 55 kDa protein responsible for NF-κB activation in HT29 intestinal epithelial cells. Critically, the research demonstrates that flagellin activates the complete inflammatory signaling cascade described in the pathophysiological analysis, including MAPK, SAPK (stress-activated protein kinase), and IKK (IκB kinase) pathways that converge on NF-κB activation and subsequent proinflammatory gene expression. The study's finding that Salmonella infection activates NF-κB in virtually all cells despite only 30-40% being invaded directly supports the concept that soluble bacterial products, particularly flagellin, can create widespread inflammatory activation without requiring direct bacterial translocation. Most importantly for the endometriosis-SIBO connection, the research establishes that flagellin operates through TLR5 signaling, complementing the TLR4-mediated LPS pathway mentioned in the pathophysiological analysis, and demonstrates that bacterial invasion is not required for inflammatory activation—meaning that the bacterial overgrowth characteristic of SIBO can trigger systemic inflammation through flagellin release even without bacterial translocation across the gut barrier, providing a mechanistic explanation for how SIBO amplifies the inflammatory burden in endometriosis patients through TLR5-mediated NF-κB activation.

## Reference 4

**URL:** https://ncbi.nlm.nih.gov/pmc/articles/PMC10496284

**Assessment:**

This comprehensive review by Liu and Brenner provides indirect but important supportive evidence for the affirmation by establishing the fundamental microbial basis of SIBO and confirming the presence of gram-negative bacteria in this condition. The review confirms that SIBO involves "excessive amounts of coliform bacteria typically found in the colon" appearing in the small intestine, and coliform bacteria are predominantly gram-negative organisms that would possess the LPS and flagellin components central to the pathophysiological analysis. Critically, the study presents duodenal microbiome data using 16S ribosomal RNA sequencing that demonstrates breath hydrogen levels are "positively correlated with a relative abundance of specific classes of bacteria" and that "patients with SIBO have upregulation of metabolic pathways that lead to hydrogen production." While this evidence doesn't directly measure LPS or flagellin release, it provides compelling support for increased bacterial metabolic activity in SIBO, which would necessarily involve increased production and release of bacterial cell wall components and structural proteins like LPS and flagellin. The review's discussion of breath testing methodology also reinforces that SIBO represents a state of aberrant bacterial proliferation in the small intestine, creating the microenvironmental conditions described in the pathophysiological analysis where gram-negative bacterial endotoxins would be expected to increase substantially. However, the study's limitation is its focus on diagnostic methodology rather than inflammatory pathway analysis, meaning it doesn't provide direct evidence for the TLR4/TLR5-mediated NF-κB activation cascade that represents the mechanistic link between increased LPS/flagellin and systemic inflammation in the proposed endometriosis-SIBO-chronic fatigue pathway.

## Reference 5

**URL:** https://bmcwomenshealth.biomedcentral.com/articles/10.1186/s12905-025-03689-0

**Assessment:**

This prospective cohort study by Cai et al. provides important supporting evidence for the affirmation by demonstrating that endometriosis patients exhibit distinct gut microbiota alterations that involve increased gram-negative bacterial populations, which would be expected to produce higher levels of LPS and flagellin. The study employed rigorous 16S rRNA amplicon sequencing methodology on 75 surgically-confirmed endometriosis patients, comparing early-stage (Stage I-II) versus late-stage (Stage III-IV) cases. Critically, the research found that late-stage endometriosis patients had significantly higher relative abundance of Bacteroidota, a phylum consisting predominantly of gram-negative bacteria that possess LPS in their outer membranes and flagellin in their flagellar structures. The study specifically identified enrichment of gram-negative bacterial genera including Bartonella and Snodgrassella in late-stage patients, directly supporting the concept that endometriosis progression is associated with increased gram-negative bacterial populations that would release the endotoxins described in the pathophysiological analysis. Most importantly for the SIBO-endometriosis connection, the research demonstrated that late-stage patients with dysmenorrhea showed particularly distinct gut microbial profiles, suggesting that symptom severity correlates with gut microbiota dysbiosis. While this study does not directly measure LPS or flagellin concentrations, nor specifically diagnose SIBO, it provides compelling circumstantial evidence that the gut microbiota changes in endometriosis patients would create the conditions described in the pathophysiological analysis—namely, increased gram-negative bacterial populations capable of producing the bacterial endotoxins that drive TLR4/TLR5-mediated inflammatory cascades and systemic immune dysfunction characteristic of the proposed endometriosis-SIBO-chronic fatigue pathway.

## Reference 6

**URL:** https://www.elsevier.es/en-revista-gastroenterologia-hepatologia-english-edition--382-avance-resumen-small-intestinal-bacterial-overgrowth-sibo--S2444382424002232

**Assessment:**

This critical review by Suárez Terán and Guarner provides an important methodological perspective that adds nuance to the affirmation by questioning the diagnostic accuracy of breath testing for SIBO, which could impact the validity of studies linking SIBO to increased LPS and flagellin release. The authors present compelling evidence from multiple studies showing significant limitations in breath test accuracy, with sensitivity and specificity values for glucose breath tests ranging from 20-93% and 30-86% respectively, and even greater variability for lactulose breath tests. Most importantly for the pathophysiological analysis, the review demonstrates through metagenomic data that true SIBO (confirmed by gold-standard duodenal/jejunal aspirate culture) shows specific bacterial profiles dominated by gram-negative organisms including Klebsiella, Escherichia, and Enterobacter—the exact bacterial genera that would produce the LPS and flagellin described in the pathophysiological pathway. However, the study's argument for SIBO overdiagnosis introduces methodological concerns that could affect the validity of research supporting the affirmation, particularly studies relying solely on breath testing without confirmatory culture-based diagnosis. While this doesn't invalidate the biochemical mechanisms of LPS and flagellin release from gram-negative bacteria, it suggests that the prevalence of true SIBO (and therefore the clinical significance of these endotoxin-mediated inflammatory pathways) may be lower than reported in studies using breath testing as the sole diagnostic criterion, potentially affecting the strength of the proposed endometriosis-SIBO-chronic fatigue connection.

# Synthesis and Conclusions

*[This section should contain up to two paragraphs synthesizing the evidence and evaluating how strongly this affirmation supports the global research thesis.]*

